CEO, PRESIDENT, STAAR SURGICAL CO.
WHY: Runs largest OC-based publicly traded company in the area’s thriving ophthalmology industry. $3B+ market value. Staar’s implantable contact lenses are used to treat a wide range of vision impairments through a surgical procedure that takes about 30 minutes on average.
RECENT: Sales growth has caught the eyes of investors: 21% growth in 2019, and 37% in 2018.
NOTABLE: Moved HQ from Monrovia to Lake Forest in 2019.
QUOTABLE: Says “the move to lens-based surgery continues” during pandemic, which is “highlighting the utility of our EVO family of lenses.”
